» Articles » PMID: 30011882

Computational Methodologies in the Exploration of Marine Natural Product Leads

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2018 Jul 18
PMID 30011882
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Computational methodologies are assisting the exploration of marine natural products (MNPs) to make the discovery of new leads more efficient, to repurpose known MNPs, to target new metabolites on the basis of genome analysis, to reveal mechanisms of action, and to optimize leads. In silico efforts in drug discovery of NPs have mainly focused on two tasks: dereplication and prediction of bioactivities. The exploration of new chemical spaces and the application of predicted spectral data must be included in new approaches to select species, extracts, and growth conditions with maximum probabilities of medicinal chemistry novelty. In this review, the most relevant current computational dereplication methodologies are highlighted. Structure-based (SB) and ligand-based (LB) chemoinformatics approaches have become essential tools for the virtual screening of NPs either in small datasets of isolated compounds or in large-scale databases. The most common LB techniques include Quantitative Structure⁻Activity Relationships (QSAR), estimation of drug likeness, prediction of adsorption, distribution, metabolism, excretion, and toxicity (ADMET) properties, similarity searching, and pharmacophore identification. Analogously, molecular dynamics, docking and binding cavity analysis have been used in SB approaches. Their significance and achievements are the main focus of this review.

Citing Articles

Advanced Technologies for Large Scale Supply of Marine Drugs.

Martinez H, Santos M, Pedraza L, Testera A Mar Drugs. 2025; 23(2).

PMID: 39997193 PMC: 11857447. DOI: 10.3390/md23020069.


Artificial Intelligence in Natural Product Drug Discovery: Current Applications and Future Perspectives.

Gangwal A, Lavecchia A J Med Chem. 2025; 68(4):3948-3969.

PMID: 39916476 PMC: 11874025. DOI: 10.1021/acs.jmedchem.4c01257.


Evaluation of fluorinated phospholipid analogs: A study on ADMET profiles, molecular docking and dynamics simulation in anticancer therapy.

Ishaq S, Habib O, Aziz A, Tahir R, Mushtaq H, Hassan S Heliyon. 2025; 11(2):e41739.

PMID: 39897839 PMC: 11787509. DOI: 10.1016/j.heliyon.2025.e41739.


Technology Readiness Level Roadmap for Developing Innovative Herbal Medicinal Products.

Pagani E, Ropke C, Soares C, Perez S, Benevides P, Barbosa B Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931370 PMC: 11206302. DOI: 10.3390/ph17060703.


Marine Drug Discovery through Computer-Aided Approaches.

Gaudencio S, Pereira F Mar Drugs. 2023; 21(8).

PMID: 37623733 PMC: 10456492. DOI: 10.3390/md21080452.


References
1.
Kangas L, Metz T, Isaac G, Schrom B, Ginovska-Pangovska B, Wang L . In silico identification software (ISIS): a machine learning approach to tandem mass spectral identification of lipids. Bioinformatics. 2012; 28(13):1705-13. PMC: 3381961. DOI: 10.1093/bioinformatics/bts194. View

2.
Plainchont B, de Paulo Emerenciano V, Nuzillard J . Recent advances in the structure elucidation of small organic molecules by the LSD software. Magn Reson Chem. 2013; 51(8):447-53. DOI: 10.1002/mrc.3965. View

3.
Takeda I, Umemura M, Koike H, Asai K, Machida M . Motif-independent prediction of a secondary metabolism gene cluster using comparative genomics: application to sequenced genomes of Aspergillus and ten other filamentous fungal species. DNA Res. 2014; 21(4):447-57. PMC: 4131838. DOI: 10.1093/dnares/dsu010. View

4.
Schneider G, Reker D, Chen T, Hauenstein K, Schneider P, Altmann K . Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide. Angew Chem Int Ed Engl. 2016; 55(40):12408-11. DOI: 10.1002/anie.201605707. View

5.
Saya J, Vos K, Kleinnijenhuis R, van Maarseveen J, Ingemann S, Hiemstra H . Total Synthesis of Aquatolide. Org Lett. 2015; 17(15):3892-4. DOI: 10.1021/acs.orglett.5b01888. View